argenx SE (EBR: ARGX)
Belgium
· Delayed Price · Currency is EUR
475.00
-4.60 (-0.96%)
Oct 8, 2024, 3:28 PM CET
argenx SE Revenue
argenx SE had revenue of $489.43M USD in the quarter ending June 30, 2024, with 74.15% growth. This brings the company's revenue in the last twelve months to $1.66B, up 98.69% year-over-year. In the year 2023, argenx SE had annual revenue of $1.27B with 187.66% growth.
Revenue (ttm)
$1.66B
Revenue Growth
+98.69%
P/S Ratio
18.28
Revenue / Employee
$1.45M
Employees
1,148
Market Cap
28.68B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.27B | 827.59M | 187.66% |
Dec 31, 2022 | 441.01M | -87.26M | -16.52% |
Dec 31, 2021 | 528.27M | 466.31M | 752.59% |
Dec 31, 2020 | 61.96M | -30.85M | -33.24% |
Dec 31, 2019 | 92.81M | 63.58M | 217.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definitionargenx SE News
- 6 days ago - Biotech Leader Argenx In Buy Zone, Poised To Hit New Highs - Investor's Business Daily
- 12 days ago - Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases - Investor's Business Daily
- 13 days ago - argenx: Myositis Data Could Add Billions In Value - Seeking Alpha
- 19 days ago - argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy - GlobeNewsWire
- 5 weeks ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Argenx raised to Overweight at Barclays on long-term prospects - Seeking Alpha
- 2 months ago - argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update - GlobeNewsWire
- 2 months ago - argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 - GlobeNewsWire